What's New View more articles
webcropdorothy.jpgVoices @ Research: My Research Path in Residency
In this edition of Voices, Dr Dorothy Ng, a Senior Resident of SingHealth Infectious Diseases reflects on her research track in residency. In her article, she pens the aspirations, difficulties, and opportunities which have taken her from medical school in London to a Junior Residency with Internal Medicine at Singapore General Hospital and an exciting stint in the Khoo Scholar programme, which gave her a research opportunity to explore dengue immunology and vaccinology research in Duke-NUS Medical School. 
lungcrop.jpg Study Links Genetic Diversity of Tumours With Resistance to Treatment in Asian Lung Cancer Patients
A study by medical oncologists from NCCS (National Cancer Centre Singapore) and scientists of A*STAR’s Genomic Institute of Singapore (GIS) have found that the genetic diversity of lung cancer tumours among Asian patients affects their response to treatment. Their findings could pave the way for more precise and tailored treatments for lung cancer patients. Lung cancer is currently the leading cause of cancer-related deaths among Singaporean men, and the second deadliest type of cancer among women here​.
Research Grand Rounds by SingHealth Office of Research 'Effectively Communicating Your Research' by Nature Research Academies
​Funded by SingHealth and Duke-NUS AMC, a workshop on 'Effectively Communicating Your Research' was conducted by the Nature Research Academies on 30 January 2018. The workshop featured trainer Dr Jeffrey Robens, Editorial Development Manager, Nature Research, and PhD from the University of Pennsylvania; and aimed to help researchers in their academic writing by spanning a total of five different writing-related topics and engaging writing activities throughout the day. Read more about the highlights of the workshop here.
tychancrop.jpg  Zika Antibody Developed By Singapore Company Ready For Human Trials 
Local clinical-stage biotechnology company Tychan has announced that its first-in-class monoclonal antibody therapeutics for Zika is now ready for human trials. Developed in a record time of nine months, the Zika therapeutics was made possible by a technology platform co-founded by Prof Ooi Eng Eong, Deputy Director, Emerging Infectious Diseases Programme, Duke-NUS and Co-Director, Viral Research and Experimental Medicine Centre@SingHealth Duke-NUS (ViREMiCS). 
Celebrating International Laboratory Animal Technician Week
​Held in early February, the International Laboratory Animal Technician Week celebrated our colleagues at the SingHealth Experimental Medicine Cetnre (SEMC) and National Large Animal Research Facility (NLARF) for their contributions to life-saving research. The week-long activities included mini games, photo contests and sharing sessions, as well as a special performance by "VetCare", a rockstar band formed by SEMC and NLARF staff!
diabetes.jpg NHCS Develops Remodelling Index to Help Patients with High Blood Pressure Prevent Heart Failure 
A team ​of researchers at the National Heart Centre's (NHCS) Department of Cardiology have developed a novel Remodelling Index (RI). According to Assistant Professor Calvin Chin, the new RI is a potentially more accurate marker to identify and risk-stratify hypertensive patients at increased risk of developing heart failure, thus enabling physicians to monitor the progression of the disease and in turn, provide more timely and appropriate treatment ot potentially delay the onset of heart failure.